Boiron Colluded On Deal Over Flu Remedies, 9th Circ. Told

Law360, Los Angeles (December 11, 2014, 6:52 PM EST) -- Boiron Inc.'s $5 million deal to end claims it falsely advertised the effectiveness of its homeopathic flu remedies shouldn't have been approved, a class member told the Ninth Circuit on Thursday, saying Boiron colluded with plaintiffs to widen the scope of the deal and doom other pending class actions.

"Your honors, this is a classic example of a collusive reverse-auction," the objector's attorney, Richard Hikida of Newport Trial Group APC, told a three-judge panel in Pasadena, California. "The release was way overbroad. ... It's astounding in terms of its breadth."

Hikida said the $5 million settlement amounts to less than 1...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!